Skip to content
Pharma Observatory a Scientist.com platform

Condition (MeSH)

Egg Hypersensitivity

ClinicalTrials.gov lists 36 trials for Egg Hypersensitivity or a narrower condition beneath it. National Institute of Allergy and Infectious Diseases (NIAID) has the most among industry and government lead sponsors, with 5.

MeSH D021181 Immune System Diseases C20
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Phase 1 Phase 1 1 Phase 1/2 Phase 1/2 4 Phase 2 Phase 2 5 Phase 2/3 Phase 2/3 1 Phase 3 Phase 3 1 Phase 4 Phase 4 1 Not applicable Not applicable 13 Observational Observational 10 Phase 1 Phase 1 1 Phase 1/2 Phase 1/2 4 Phase 2 Phase 2 5 Phase 2/3 Phase 2/3 1 Phase 3 Phase 3 1 Phase 4 Phase 4 1 Not applicable Not applicable 13 Observational Observational 10

Trials per phase

36 of the 36 trials are tagged with Egg Hypersensitivity itself; the rest are tagged with a narrower condition beneath it.

Get the Egg Hypersensitivity report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

When did Egg Hypersensitivity trials start? (20)

Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Trials over time, by phase

  • Phase 1/2
  • Phase 2
  • Phase 2/3
  • Phase 4
  • Not applicable
  • Observational

Top of scale: 5

2002: 1 trials (Not applicable 1) 2003: 1 trials (Not applicable 1) 2006: 2 trials (Observational 1, Phase 2 1) 2007: 1 trials (Phase 2 1) 2008: 1 trials (Phase 1/2 1) 2010: 3 trials (Observational 1, Not applicable 1, Phase 1/2 1) 2011: 1 trials (Phase 2 1) 2012: 1 trials (Observational 1) 2013: 5 trials (Observational 3, Not applicable 1, Phase 2 1) 2014: 1 trials (Phase 4 1) 2015: 3 trials (Observational 1, Not applicable 2) 2018: 1 trials (Observational 1) 2019: 1 trials (Not applicable 1) 2020: 1 trials (Not applicable 1) 2021: 2 trials (Not applicable 1, Phase 1/2 1) 2022: 2 trials (Not applicable 1, Phase 1/2 1) 2023: 1 trials (Not applicable 1) 2024: 1 trials (Observational 1) 2025: 4 trials (Not applicable 2, Phase 2/3 1, Phase 2 1)

Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 3
2025 4
2024 1
2023 1
2022 2
2021 2
2020 1
2019 1
2018 1
2015 3

No forecast is made for this condition: it averages 2.2 trial starts a year over the five years to September, under the 5 a year the method needs.

Recruitment duration, a model prediction: 4 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

What phase are Egg Hypersensitivity trials in? (8)

Shown in this order: phase order.

Show the trials by phase as a table
Trials by phase
Phase Trials
Phase 1 1
Phase 1/2 4
Phase 2 5
Phase 2/3 1
Phase 3 1
Phase 4 1
Not applicable 13
Observational 10

How many Egg Hypersensitivity trials are recruiting? (7)

Shown in this order: the order a trial moves through, from not yet recruiting to unknown.

Trials by recruitment status
Status Trials
Not yet recruiting 1
Recruiting 7
Active, not recruiting 1
Completed 19
Terminated 2

Status as registered on ClinicalTrials.gov. Each trial is counted once.

Which lead sponsors run the most Egg Hypersensitivity trials? (5)

Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Lead sponsors
Sponsor Trials
National Institute of Allergy and Infectious Diseases (NIAID) 5
Alladapt Immunotherapeutics, Inc. 2
Bayside Health 1
Candid Therapeutics 1
KK Women's and Children's Hospital 1

Interventions as named in the registry (15)

Shown in this order: most trials first.

Interventions as named in the registry
Drug Trials
Administration of Live attenuated influenza vaccine 2
Egg Oral Immunotherapy 2
Administration of wine fined with potential food allergens 1
ADP101 1
Control (placebo) group 1

These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.

Which serious adverse events do Egg Hypersensitivity trials report? (10)

Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.

Serious adverse events in this condition's trials
Adverse event Subjects affected Trials
Wheezing 50 2
Anaphylactic reaction 23 3
Asthma 22 2
Gastroenteritis 9 1
Febrile convulsion 6 1

Which publications cover Egg Hypersensitivity? (42)

Shown in this order: major-topic papers first, then newest, then most linked to trials.

Publications
Publication Journal Year Major topic
Systematic review and meta-analyses on the accuracy of diagnostic tests for IgE-mediated food allergy. Allergy 2024 Yes
Partial Egg Consumption Modifies the Diagnostic Performance of Allergy Tests to Predict Outcome of Double-Blind Placebo-Controlled Food Challenges to Egg. The journal of allergy and clinical immunology. In practice 2024 Yes
Design of the Intervention to Reduce Early Peanut Allergy in Children (iREACH): A practice-based clinical trial. Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 2024 Yes
The Safety and Efficacy of Baked Egg and Milk Dietary Advancement Therapy: A Systematic Review and Meta-Analysis. The journal of allergy and clinical immunology. In practice 2024 Yes
The role of basophil activation test and component-resolved diagnostics in the workup of egg allergy in children at low risk for severe allergic reactions: A real-life study. Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 2023 Yes

Not on this page

Not measured: delivery record.

Checked, with nothing recorded for this condition: prevalence, rare-disease identity, and sub-conditions in mesh.

Browse all condition evidence pages